Ploy MC et al. |
[Antibacterial activity of clarithromycin and its hydroxylated derivative and two other macrolides against thirty strains of Streptococcus pneumoniae]. |
1994 |
Pathol. Biol. |
pmid:7824300
|
Gevaudan MJ et al. |
[Evaluation of the extra- and intracellular activity of clarithromycin against Mycobacterium chelonae]. |
1994 |
Pathol. Biol. |
pmid:7824305
|
Rolinson GN |
A clarithromycin sensitivity survey. |
1994 |
J. Antimicrob. Chemother. |
pmid:7829420
|
Durodie J and Slocombe B |
A clarithromycin sensitivity survey. |
1994 |
J. Antimicrob. Chemother. |
pmid:7829421
|
Sano M et al. |
[Inhibition of biofilm formation by clarithromycin (CAM) in an experimental model of complicated bladder infection--in vitro study using automated simulation of urinary antimicrobial concentration]. |
1994 |
Kansenshogaku Zasshi |
pmid:7829898
|
Sieber CC et al. |
[Helicobacter pylori resistance against metronidazole in Switzerland: implications for eradication therapy?]. |
1994 |
Schweiz Med Wochenschr |
pmid:8091165
|
Terashima T et al. |
Pulmonary infection due to Mycobacterium xenopi. |
1994 |
Intern. Med. |
pmid:8000103
|
Fish DN et al. |
Penetration of clarithromycin into lung tissues from patients undergoing lung resection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031063
|
Bonnet E et al. |
Clarithromycin: a potent agent against infections due to Mycobacterium marinum. |
1994 |
Clin. Infect. Dis. |
pmid:8038339
|
Lemmen SW et al. |
Bactericidal activity of clarithromycin and cefaclor against Streptococcus pneumoniae and Moraxella catarrhalis in healthy volunteers. |
1994 |
J. Antimicrob. Chemother. |
pmid:8040139
|
Dautzenberg B et al. |
[Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection]. |
1994 |
Rev Mal Respir |
pmid:8041990
|
Ishida K et al. |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031048
|
al-Assi MT et al. |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. |
1994 |
Am. J. Gastroenterol. |
pmid:8053435
|
Xiong JH et al. |
Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice. |
1994 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:8189087
|
Paffetti A et al. |
[Clarithromycin in pediatric age. Personal experience]. |
1994 |
Minerva Pediatr. |
pmid:8084327
|
Saran BR et al. |
Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. |
1994 |
Arch. Ophthalmol. |
pmid:8085960
|
Yew WW et al. |
Cholestatic hepatitis in a patient who received clarithromycin therapy for a Mycobacterium chelonae lung infection. |
1994 |
Clin. Infect. Dis. |
pmid:8086541
|
Zahid MA et al. |
Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin. |
1994 |
Clin. Infect. Dis. |
pmid:8086568
|
Sano M et al. |
[Adaptation study for biofilm of the urinary tract via highly complicated bladder model (biofilm model of the urinary tract)--experimental study using automatic simulator of the urinary antimicrobial agent concentration]. |
1994 |
Kansenshogaku Zasshi |
pmid:8089557
|
|
AIDS patients have a new weapon against MAC infection. |
1994 |
RN |
pmid:8128150
|
Fujii K et al. |
In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8067748
|
Honeybourne D et al. |
The levels of clarithromycin and its 14-hydroxy metabolite in the lung. |
1994 |
Eur. Respir. J. |
pmid:7925906
|
Shafran SD et al. |
Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network. |
1994 |
N. Engl. J. Med. |
pmid:8284019
|
Meier A et al. |
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192472
|
Labenz J et al. |
[Omeprazole modified antibiotic therapy of Helicobacter pylori infection: can clarithromycin be replaced by roxithromycin?]. |
1994 |
Leber Magen Darm |
pmid:8196468
|
Chan GP et al. |
Clinical trial of clarithromycin for lepromatous leprosy. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203847
|
Onyeji CO et al. |
Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203849
|
Klemens SP and Cynamon MH |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986001
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
Jones RN et al. |
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards. |
1994 |
Diagn. Microbiol. Infect. Dis. |
pmid:7924221
|
Olliaro P et al. |
In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii. |
1994 |
J. Antimicrob. Chemother. |
pmid:7706160
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Cynamon MH et al. |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979270
|
Klemens SP and Cynamon MH |
Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979271
|
Kanatani MS and Guglielmo BJ |
The new macrolides. Azithromycin and clarithromycin. |
1994 |
West. J. Med. |
pmid:8128699
|
|
Antibiotic gets FDA nod for MAC treatment. |
1994 |
Am J Nurs |
pmid:8304386
|
Walker KJ et al. |
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7811010
|
Price DA et al. |
Clinical response to the addition of clarithromycin in Pneumocystis carinii pneumonia refractory to high dose co-trimoxazole. |
1994 |
J. Antimicrob. Chemother. |
pmid:7814298
|
Tahara RW et al. |
The question of clarithromycin: a first-line drug for sinusitis? |
1994 |
Arch Fam Med |
pmid:7818657
|
Pustorino S et al. |
[Effects of intravenous administration of clarithromycin on plasma levels of gastrin and group I pepsinogen]. |
1994 |
Clin Ter |
pmid:7820984
|
Alder J et al. |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine. |
1994 |
J. Acquir. Immune Defic. Syndr. |
pmid:7932081
|
Ferrari SL et al. |
The interaction between clarithromycin and cyclosporine in kidney transplant recipients. |
1994 |
Transplantation |
pmid:7940695
|
Tomono K |
[Therapeutic efficacy of macrolide in pulmonary nontuberculous mycobacteriosis]. |
1994 |
Kekkaku |
pmid:7837727
|
Sanchez T et al. |
Quantitation of mycobacteria in blood specimens from patients with AIDS. |
1994 |
Tuber. Lung Dis. |
pmid:7841433
|
Sungur C |
Acute rheumatic fever despite clarithromycin treatment of beta-hemolytic streptococcal tonsillitis. |
1994 |
Ann Pharmacother |
pmid:7841580
|
Maass M and Dalhoff K |
[Isolation of Chlamydia pneumoniae in atypical pneumonia]. |
1994 |
Dtsch. Med. Wochenschr. |
pmid:7956770
|
Verbist L and Dhoore F |
In vitro susceptibility of recently isolated respiratory tract pathogens to minocycline and comparable antibiotics. A multicentre study. |
1994 |
Acta Clin Belg |
pmid:7871933
|
Ji B et al. |
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872741
|
Skinner PS et al. |
A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872747
|
Valero G et al. |
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872769
|